Endress+Hauser AG:企業の戦略的SWOT分析

◆英語タイトル:Endress+Hauser AG - Strategic SWOT Analysis Review
◆商品コード:DATA904C5256
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:産業装置
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Endress+Hauser AG – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Endress+Hauser AG (Endress+Hauser) is a provider of instrumentation and process automations solutions. The company operates through its entities to offer measurement instruments, services and automation solutions for industrial process engineering applications. Its product portfolio comprises of sensors, instruments and systems for level, flow, temperature and pressure measurements, liquid analysis and data acquisition. It also provides engineering services such as project management, and automation services. It serves customers in multiple markets, including chemical, petrochemical, water and wastewater, food and beverage, life science, power and energy, oil and gas, pulp and paper, and shipbuilding. The company has operational presence in Europe, Americas, Asia-Pacific, Africa and Middle East. Endress+Hauser is headquartered in Reinach, Switzerland.

Endress+Hauser AG Key Recent Developments

Feb 08,2018: Sinanju Tankers Complete Bunkering Fleet Expansion
Jan 09,2018: Endress+Hauser forms partnership to provide digital oilfield technology

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
Section 1 – About the Company 5
Endress+Hauser AG – Key Facts 5
Endress+Hauser AG – Key Employees 6
Endress+Hauser AG – Key Employee Biographies 7
Endress+Hauser AG – Major Products and Services 8
Endress+Hauser AG – History 9
Endress+Hauser AG – Company Statement 12
Endress+Hauser AG – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 17
Company Overview 17
Endress+Hauser AG – Business Description 18
Endress+Hauser AG – SWOT Analysis 19
SWOT Analysis – Overview 19
Endress+Hauser AG – Strengths 19
Endress+Hauser AG – Weaknesses 20
Endress+Hauser AG – Opportunities 21
Endress+Hauser AG – Threats 22
Endress+Hauser AG – Key Competitors 23
Endress+Hauser AG, Recent Deals Summary 24
Section 3 – Company’s Recent Developments 25
Jan 09, 2018: Endress+Hauser forms partnership to provide digital oilfield technology 25
Jan 09, 2018: Endress+Hauser forms partnership to provide digital oilfield technology 26
Jan 09, 2018: Endress+Hauser forms partnership to provide digital oilfield technology 27
Section 4 – Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
Endress+Hauser AG, Key Facts 5
Endress+Hauser AG, Key Employees 6
Endress+Hauser AG, Key Employee Biographies 7
Endress+Hauser AG, Major Products and Services 8
Endress+Hauser AG, History 9
Endress+Hauser AG, Other Locations 13
Endress+Hauser AG, Subsidiaries 14
Endress+Hauser AG, Key Competitors 23
Endress+Hauser AG, Recent Deals Summary 24

★海外企業調査レポート[Endress+Hauser AG:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Rafael Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), formerly Cornerstone Pharmaceuticals Inc, is a clinical-stage, metabolic oncology therapeutics company, which focuses to develop and commercialize cancer metabolism based drugs. The company’s lead drug candidate CPI-613 is designed to targ …
  • Accuray Inc (ARAY):医療機器:M&Aディール及び事業提携情報
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • Daktronics Inc (DAKT):企業の財務・戦略的SWOT分析
    Daktronics Inc (DAKT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • YKK Corporation:企業の戦略・SWOT・財務情報
    YKK Corporation - Strategy, SWOT and Corporate Finance Report Summary YKK Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Wheaton Precious Metals Corp:企業の戦略・SWOT・財務情報
    Wheaton Precious Metals Corp - Strategy, SWOT and Corporate Finance Report Summary Wheaton Precious Metals Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Sihuan Pharmaceutical Holdings Group Ltd (460):企業の財務・戦略的SWOT分析
    Summary Sihuan Pharmaceutical Holdings Group Ltd (Sihuan Pharmaceutical) is a pharmaceutical company that develops, manufactures and markets prescription drugs. The company offers products in the therapeutic areas of cardio-cerebral vascular system, central nervous system, metabolism, oncology and a …
  • Actinogen Medical Ltd (ACW):企業の財務・戦略的SWOT分析
    Summary Actinogen Medical Ltd (Actinogen), formerly Actinogen Ltd is a biotechnology company that develops novel treatments for alzheimer’s disease and the cognitive decline associated with neurodegenerative diseases and metabolic diseases. The company’s xanamem is a novel drug under development for …
  • Astex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product, Dacogen (indicated for the treatment of myel …
  • Flint Group:企業の戦略・SWOT・財務分析
    Flint Group - Strategy, SWOT and Corporate Finance Report Summary Flint Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Korea East-West Power Co Ltd-エネルギー分野:企業M&A・提携分析
    Summary Korea East-West Power Co., Ltd. (EWP), subsidiary of Korea Electric Power Corporation, is a state-owned electric utility that generates and supplies electricity. It produces electricity from various sources including coal, oil, liquefied natural gas, mini hydro, and renewable sources such as …
  • Magma Fincorp Limited:企業のM&A・事業提携・投資動向
    Magma Fincorp Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Magma Fincorp Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Carmanah Technologies Corporation (CMH):電力:M&Aディール及び事業提携情報
    Summary Carmanah Technologies Corporation (Carmanah Technologies) is a provider of signal and solar-based light emitting diode (LED) solutions for infrastructure. The company designs, develops and distributes solar powered LED lighting, and solar powered systems and equipment. It also designs, devel …
  • Genmab AS (GEN):製薬・医療:M&Aディール及び事業提携情報
    Summary Genmab A/S (Genmab) is a biotechnology company that develops differentiated human antibody therapeutics for the treatment of cancer. The company's marketed antibody, ofatumumab (Arzerra) and Daratumumab (Darzalex) are indicated for the treatment of chronic lymphocytic leukemia and multiple m …
  • Teijin Ltd (3401):製薬・医療:M&Aディール及び事業提携情報
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Nakanishi Inc (7716):企業の財務・戦略的SWOT分析
    Nakanishi Inc (7716) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Marina Portoroz dd:企業の戦略・SWOT・財務分析
    Marina Portoroz dd - Strategy, SWOT and Corporate Finance Report Summary Marina Portoroz dd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Korea Research Institute of Bioscience and Biotechnology:製薬・医療:M&Aディール及び事業提携情報
    Summary Korea Research Institute of Bioscience and Biotechnology (KRIBB) is a government research institute which provides bioinformatic services. The institute operates in the fields of strategic research, biomedical sciences, system biology and bioengineering, business development, and bioinfrastr …
  • Hoegh LNG Holdings Ltd (HLNG):企業の財務・戦略的SWOT分析
    Summary Hoegh LNG Holdings Ltd (Hoegh LNG), formerly known as Leif Hoegh & Co Ltd is an oil and gas company that offers floating energy solutions. The company's services include floating storage and regasification unit solutions, in-house ship management, floating LNG energy services, LNG regasifica …
  • Attock Refinery Ltd (ATRL):企業の財務・戦略的SWOT分析
    Summary Attock Refinery Ltd (ARL), a subsidiary of The Attock Oil Co Ltd, is a downstream company that offers refining services. The company refines crude oil and supplies refined petroleum products. Its products include liquefied petroleum gas, petroleum solvent, naphtha, unleaded premium motor gas …
  • NuVista Energy Ltd (NVA):石油・ガス:M&Aディール及び事業提携情報
    Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian Sedimentary Basin which is located in West Central Alberta and Northeast British Columbia areas …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆